BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38301499)

  • 1. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
    Wu J; Wang R; Chen W; Wu Y; Xiao L
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
    [No Abstract]   [Full Text] [Related]  

  • 3. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
    Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
    World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer.
    Tu Y; Jiang P; Zhang J; Jiang S; Yi Q; Yuan R
    Int J Gynaecol Obstet; 2022 Aug; 158(2):330-337. PubMed ID: 34735721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored radical hysterectomy for locally advanced cervical cancer.
    Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
    Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
    Zou T; Zheng C; Zhang Z; Yu L; Fu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy.
    Wang D; Wu M; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Chin Med J (Engl); 2013; 126(8):1464-8. PubMed ID: 23595378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer.
    Jia M; Pi J; Zou J; Feng M; Chen H; Lin C; Yang S; Xiao X
    Cancer Control; 2023; 30():10732748231206929. PubMed ID: 37924202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer.
    Wang H; Zhu L; Lu W; Xu H; Yu Y; Yang Y
    World J Surg Oncol; 2013 Nov; 11():301. PubMed ID: 24266990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
    Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
    J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.